May 16, 2013
International leaders to discuss today's issues from cell line selection to manufacturing. Summit to feature an expanded roster of meetings with increased formulation foci plus new meetings delving into early IND strategies and biomanufacturing.
May 08, 2013
The 2013 Next Generation Dx Summit to bring together all of the major players in the evolving areas of diagnostics.
Apr 23, 2013
Just released: final agenda. Hear the latest approaches to CTC capture and molecular profiling from 16 prominent scientists in 3 comprehensive sessions.
Apr 18, 2013
New, expanded format includes 2 day and a half conferences presenting the points of view of all stakeholders involved in the process of companion diagnostic test design, manufacturing, clinical implementation and reimbursement.
Apr 10, 2013
Cambridge Healthtech Institute (CHI) is proud to host its Inaugural FAST: Functional Analysis & Screening Technologies Congress, October 28-30, 2013 in Cambridge, Mass. Speaker proposals will be accepted until April 19, 2013.
Mar 26, 2013
Drugging the Undruggable: Transforming Nature’s α-Helix into Breakthrough Medicines will be discussed at CHI's 13th Annual Structure-Based Drug Design Conference this coming...
Mar 22, 2013
Chemical Computing Group will host a dinner short course in Boston, MA, on June 19, 2013, from 6:00-8:00 pm, on the conclusion of day one of CHI/Bio-IT World’s 13th annual Structure-Based Drug Design (SBDD) conference taking place at the Revere Hotel...
Mar 20, 2013
Mar. 20, 2013 - Needham, MA - Part of Cambridge Healthtech Institute’s Bio-IT World Expo, attendees will gain first-hand insight from three plenary keynote presentations, aligned with the event theme of new trends in data generation, knowledge...
Mar 12, 2013
Bio-IT World has announced that complimentary keynote and exhibit hall passes are now available for the 2013 Bio-IT World Expo, taking place April 9-11 in Boston, MA.
Feb 22, 2013
The Accelerating Development of Difficult-to-Deliver Drugs conference will discuss the role of novel delivery strategies and advanced tools in developing difficult-to-deliver drugs.